...
首页> 外文期刊>Vaccine >Enteral vaccination of rats against Fasciola hepatica using recombinant cysteine proteinase (cathepsin L1)
【24h】

Enteral vaccination of rats against Fasciola hepatica using recombinant cysteine proteinase (cathepsin L1)

机译:使用重组半胱氨酸蛋白酶(cathepsin L1)对大鼠进行肝肠Fasciola肝疫苗接种

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cysteine proteinases released by Fasciola hepatica play a key role in parasite feeding, migration through host tissues and in immune evasion. Hence, a recombinant cysteine proteinase (CPFhW) expressed as inclusion bodies in Escherichia coli was used for enteral vaccination of rats against fasciolosis. We managed to activate this proteinase and found it to have cathepsin L1-like substrate preference. Enteral vaccination of rats induced a 78-80% protection against challenge with fluke metacercariae (mc). The immunised rats showed clear immunological response. The challenge with mc caused a remarkable infiltration of eosinophils into the peritoneal cavity of both the vaccinated rats and challenge control rats. However, CD8+ and CD4+ lymphocytes appeared in significantly higher numbers in the peritoneal fluid of vaccinated rats than in controls.
机译:Fasciola hepatica释放的半胱氨酸蛋白酶在寄生虫摄食,通过宿主组织的迁移和逃避免疫中起关键作用。因此,在大肠杆菌中表达为包涵体的重组半胱氨酸蛋白酶(CPFhW)被用于大鼠针对肠球菌病的肠内疫苗接种。我们设法激活了这种蛋白酶,发现它具有组织蛋白酶L1样底物偏好。大鼠的肠内疫苗接种可诱导78-80%的抗meta尾fl(mc)攻击。免疫的大鼠表现出明显的免疫反应。 mc激发使免疫嗜酸性粒细胞显着渗入接种疫苗的大鼠和激发对照大鼠的腹膜腔。然而,在接种疫苗的大鼠的腹膜液中,CD8 +和CD4 +淋巴细胞的数量明显高于对照组。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号